Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kazuyuki Fujishima is active.

Publication


Featured researches published by Kazuyuki Fujishima.


European Journal of Pharmacology | 1989

Potentiation of stretch-induced myogenic tone of dog cerebral artery by hemolysate and the inhibitory action of calcium antagonists

Koichi Nakayama; Yoshio Tanaka; Kazuyuki Fujishima

Quick stretching of a helical strip of dog basilar artery at a rate of 10 cm/s to 140% of the slack length of the muscle evoked a delayed contraction. A small amount of hemolysate (0.01-0.2 mg/ml as hemoglobin), which increased the basal tone by 10-15% of the maximum contracture produced by 80 mM K+, potentiated the stretch-induced contraction 2- to 3-fold over the control. The enhanced response to stretch was attenuated by removal of the endothelium and was readily suppressed by Ca2+ antagonists such as nisoldipine and other dihydropyridine drugs as well as diltiazem. The hemolysate had no apparent effect on the contraction due to a quick stretch in Ca2+-free medium or on the contractile response of a chemically skinned arterial strip in the relaxing solution. The results suggest that the hemolysate potentiates the contractile response to stretch by promoting the transmembrane supply of Ca2+. The presence of endothelium seems to amplify the vasoconstrictor action of the hemolysate.


European Journal of Pharmacology | 1995

Pharmacological profile of ME3221, a novel angiotensin II receptor antagonist

Jun Nagura; Sumie Yasuda; Kazuyuki Fujishima; Mikio Yamamoto; Chen Hui; Ken-ichi Kawano; Kiyoaki Katano; Hiroko Ogino; Mitsugu Hachisu; Fukio Konno


Archive | 2004

M-substituted benzoic acid derivatives having integrin alpha v beta 3 antagonistic activity

Keiichi Ajito; Minoru Ishikawa; Dai Kubota; Shoichi Murakami; Mikio Yamamoto; Naokazu Yahata; Kazuyuki Fujishima; Makoto Oyama


Archive | 2001

Remedies for reperfusion injury containing integrin alphanubeta 3 antagonist

Kazuyuki Fujishima; Shoichi Murakami; Mikio Yamamoto; Mitsuhiro Abe; Minoru Ishikawa; Shokichi Ouchi; Keiichi Ajito


European Journal of Pharmacology | 1998

Nonpeptide angiotensin II receptor antagonist recognizes inter-species differences in angiotensin AT1 receptors

Ken-ichi Kawano; Kazuyuki Fujishima; Jun Nagura; Sumie Yasuda; Shinki; Mitsugu Hachisu; Fukio Konno


Folia Pharmacologica Japonica | 1998

[Effects of amrinone on renal blood flow and cardiac function, in comparison with those of milrinone and olprinone, in anesthetized dog].

Kazuyuki Fujishima; Mitugu Hachisu


Archive | 2000

Ω-amino-α-hydroxycarboxylic acid derivatives having integrin ανβ3 antagonistic activity

Keiichi Ajito; Naokazu Yahata; Minoru Ishikawa; Dai Kubota; Shoichi Murakami; Mikio Yamamoto; Kazuyuki Fujishima; Shuichi Gomi; Shokichi Ouchi


Archive | 1998

5-(4-Piperidinyl)dibenzothiazepine derivatives and 5-(4-piperidinyl)dibenzoxazepine derivatives, and antiarrhythmic agents

Kiyoaki Katano; Takahiko Satoh; Tomoko Soneda; Naoko Kamitoh; Kazuyuki Fujishima; Mitsugu Hachisu


Archive | 2001

REMEDIES FOR REPERFUSION INJURY CONTAINING INTEGRIN αvβ3 ANTAGONIST

Kazuyuki Fujishima; Shoichi Murakami; Mikio Yamamoto; Mitsuhiro Abe; Minoru Ishikawa; Shokichi Ouchi; Keiichi Ajito


Archive | 2001

REMEDES DESTINES A UNE LESION PAR REPERFUSION CONTENANT UN ANTAGONISTE D'INTEGRINE αvβ3

Kazuyuki Fujishima; Shoichi Murakami; Mikio Yamamoto; Mitsuhiro Abe; Minoru Ishikawa; Shokichi Ouchi; Keiichi Ajito

Collaboration


Dive into the Kazuyuki Fujishima's collaboration.

Top Co-Authors

Avatar

Keiichi Ajito

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge